Patient ID : SB2705250701 /OPD Sample Coll Date : 27-May-2025 09.
45 AM
Patient Name : MRS. SHUBHANGI GUPTA Regn Date : 27-May-2025 09.45 AM
Age / Gender : 21 Years / Female Report Date : 27-May-2025 11.45 AM
Referred By Dr. : SAARTHI HOSPITAL BHANDUP Contact No :
Barcode *SB2705250701
CBC (6 Part)
Investigation Result Unit Bio. Ref. Interval
Erythrocytes
HAEMOGLOBIN (Hb) 15.3 gm/dl 11.0 - 15.0
Method : Colorimetric
Erythrocyte (RBC) COUNT 5.35 /uL 3.50 - 5.00
Method : Electrical Impedance
PCV (Packed Cell Volume) 46.5 % 37 - 47
Method : Calculated
MCV (Mean Corpuscular Volume) 86.9 fl 80 - 100
Method : RBC Histogram
MCH (Mean Corpuscular Hb) 28.6 pg 27 - 34
Method : Calculated
MCHC (Mean Corpuscular 32.9 g/dl 32 - 36
Concn.)
Method : Calculated
RDW (Red Cell Distribution 15.2 % 11.0 - 16.0
Width)
Method : RBC Histogram
Leucocytes
Total Leucocytes (WBC) COUNT 23620 /uL 4000 - 10000
Method : Flow Cytometry
NEUTROPHILS 85 % 50 - 70
Method : Flow cytometry
LYMPHOCYTES 09 % 20 - 40
Method : Flow Cytometry
EOSINOPHILS 01 1-6
Method : Flow cytometry
MONOCYTES 05 % 3 - 12
Method : Flow Cytometry
BASOPHILS 00 % 0-1
Absolute Neutrophil Count 20340.00 /uL 1600 - 8000
Calculated
Absolute LYMPHOCYTES Count 2050 /uL 800 - 4000
Calculated
Absolute Eosinophil Count 236.2 /uL 0 - 600
Patient ID : SB2705250701 /OPD Sample Coll Date : 27-May-2025 09.45 AM
Patient Name : MRS. SHUBHANGI GUPTA Regn Date : 27-May-2025 09.45 AM
Age / Gender : 21 Years / Female Report Date : 27-May-2025 11.45 AM
Referred By Dr. : SAARTHI HOSPITAL BHANDUP Contact No :
Barcode *SB2705250701
CBC (6 Part)
Investigation Result Unit Bio. Ref. Interval
Calculated
PLATELET
PLATELET COUNT 445000 /uL 150000 - 450000
Method : Electrical Impedance
MPV (Mean Platelet Volume) 8.4 fl 6.5 - 12.0
Method : PLT Histogram
PCT (Platelet Haematocrit) 0.38 % 0.10 - 0.28
Method : PLT Histogram
PDW (Platelet Distribution Width) 16.1 % 15.0 - 17.0
Method : PLT Histogram
PERIPHERAL SMEAR EXAMINATION
WBC MORPHOLOGY Neutrophilic Leucocytosis
RBC MORPHOLOGY Normochromic Normocytic
PLATELETS ON SMEAR Adequate
Method : Microscopy
Test is done on Fully Automated 6-Part Hematology analyzer "MINDRAY BC-6000"
Test done from EDTA Whole Blood.
---------------- END OF REPORT ---------------
Dr. Arun Sali
Checked By
(MD Pathologist)
Page 2 of 4 MC-7327
Patient ID : SB2705250701 /OPD Sample Coll Date : 27-May-2025 09.45 AM
Patient Name : MRS. SHUBHANGI GUPTA Regn Date : 27-May-2025 09.45 AM
Age / Gender : 21 Years / Female Report Date : 27-May-2025 12.58 PM
Referred By Dr. : SAARTHI HOSPITAL BHANDUP Contact No :
Barcode *SB2705250701
BIOCHEMISTRY..
Investigation Result Unit Bio. Ref. Interval
Renal Function Test
Sr. Blood Urea 28.5 mg/dL 13-45
(Method : Urease,colorimetric)
Blood Urea Nitrogen 13.31 mg/dL 6 - 20
Sr. Creatinine 1.63 mg/dL Male: 0.7 - 1.3 mg/dl
Female: 0.6 – 1.1 mg/dl
Newborn: 0.3 – 1.1 mg/dl
Infant: 0.2 – 0.4 mg/dl
Child: 0.3 – 0.7
Adolescent: 0.5 – 1.0 mg/dl
(Method : JAFFES KINETIC)
Sr. Uric Acid 4.2 mg/dL 2.3-6.6
(Method : Uricase,colorimetric)
Sr. Phosphorous 5.49 mg/dL 2.8 - 4.8
(Method : Ammonium molybdate UV)
Sr. Calcium 12.3 mg/dL 8.6 - 10.2
(Method : Arsenazo III)
Sr. Sodium 140.2 mEq/lit 136 - 145
Method : ISE Indirect
Sr. Potassium 5.98 mEq/lit 3.5 - 5.1
Method: ISE Indirect
Serum Chloride 107.5 mEq/L 98 - 107
Method: ISE Indirect
INTERPRETATION :
Kidney function tests (KFT) are performed for evaluation of kidney function. The blood urea nitrogen or BUN test is primarily used, along
with the creatinine test, to evaluate kidney function in a wide range of circumstances, to help diagnose kidney disease, and to monitor
people with acute or chronic kidney dysfunction or failure. 1. Blood Urea Nitrogen (BUN) - Urea is a waste product formed in the liver
when protein is metabolized. Urea is released by the liver into the blood and is carried to the kidneys, where it is filtered out of the blood
and released into the urine. 2. Creatinine - Creatinine is a waste product produced by muscles from the breakdown of a compound called
creatine. Almost all creatinine is filtered from the blood by the kidneys and released into the urine, so blood levels are usually a good
indicator of how well the kidneys are working. 3. Uric acid - The uric acid blood test is used to detect high levels of this compound in the
blood in order to help diagnose recurrent kidney stones and gout. The test is also used to monitor uric acid levels in people undergoing
chemotherapy or radiation treatment for cancer.
SGOT
Serum SGOT (AST) 31.4 IU/L 0-31
Patient ID : SB2705250701 /OPD Sample Coll Date : 27-May-2025 09.45 AM
Patient Name : MRS. SHUBHANGI GUPTA Regn Date : 27-May-2025 09.45 AM
Age / Gender : 21 Years / Female Report Date : 27-May-2025 12.52 PM
Referred By Dr. : SAARTHI HOSPITAL BHANDUP Contact No :
Barcode *SB2705250701
BIOCHEMISTRY..
Investigation Result Unit Bio. Ref. Interval
INTERPRETATION :
SGOT is an enzyme found mainly in heart muscle, liver cells, skeletal muscle and kidneys. Injury to these tissues results in the release of
the enzyme in blood. Elevated levels are found in myocardial infraction, cardiac operations, Hepatitis, Cirrhosis, acute renal diseases,
promary muscle diseases. Decreased levels may be found in pregnancy, Beri Beri and diabetic ketoacidosis. Normally, levels of AST in the
blood are low. Very high levels of AST (more than 10 times normal) are usually due to acute hepatitis, sometimes due to a viral infection.
With chronic hepatitis, AST levels are usually not as high, often less than 4 times normal, and are more likely to be normal than are ALT
levels.
SGPT
Serum SGPT (ALT) 23.1 IU/L 0-34
INTERPRETATION :
SGPT (ALT) is found in a variety of tissues but is mainly found in the liver. Increased levels are found in hepatitis, cirrhosis, obstructive
jaundice and other hepatic diseases. Slight elevation of the enzymes is also seen in myocardial infraction. Normally, levels of ALT in the
blood are low. Very high levels of ALT (more than 10 times normal) are usually due to acute hepatitis, sometimes due to a viral infection.
Other causes of moderate increases in ALT include obstruction of bile ducts, cirrhosis (usually the result of chronic hepatitis or bile duct
obstruction), heart damage, alcohol abuse, and with tumors in the liver.
Bilirubin Total, Direct, Indirect
Serum Bilirubin-Total 0.41 mg/dL 0.2 – 1
(Method : Diazotization)
Serum Bilirubin-Direct 0.19 mg/dL 0-0.2
(Method : Diazotization)
Serum Bilirubin- Indirect 0.22 mg/dL 0.1-1.0
INTERPRETATION :
Bilirubin is an orange-yellow pigment, a waste product primarily produced by the normal breakdown of heme. A bilirubin test is used to
detect an increased level in the blood. It may be used to help determine the cause of jaundice and/or help diagnose conditions such as
liver disease, hemolytic anemia, and blockage of the bile ducts. Increased total bilirubin that is mainly unconjugated (indirect) bilirubin
may be a result of Hemolytic or pernicious anemia, transfusion reaction and cirrhosis. If conjugated (direct) bilirubin is elevated more than
unconjugated (indirect) bilirubin, there typically is a problem associated with decreased elimination of bilirubin by the liver cells. Some
conditions that may cause this include viral hepatitis, Drug reactions and alcoholic liver disease.
---------------- END OF REPORT ---------------
Dr. Arun Sali
Checked By
(MD Pathologist)
Page 4 of 4 MC-7327
